Take a look back at our most popular news from November 2022.
Did you miss the top stories on Drug Topics® this month? Catch up on these noteworthy stories today.
10. Science Communication Tips for Pharmacists
Pharmacists can help educate patients as they try to analyze scientific information shared via the news or social media.
9. Keys to Managing Gestational Diabetes in the Pharmacy
Patients can face risks like hypertension and difficult delivery.
8. Are Cannabinoids Key to Harm Reduction in Opioid Use Disorder?
Cannabinoids lack the habit-forming mechanism of action found in methadone and buprenorphine, unlocking new potential for the drug.
7. Tackling Pneumonia in the Pharmacy
Besides providing education and counseling, pharmacists play a key role in the administration of vaccines.
6. Text Message Reminders Raise Flu Vaccination Rates
In a recent study, researchers found that text message reminders led to increased influenza vaccination rates, along with many receiving the vaccine sooner.
It’s too late for retail chain pharmacies to engage in the preventive maintenance that would have spared them the worst of the Great Resignation.
4. The Implications of Opioid Use in Treating Cancer-Related Pain
As the main course of treatment for cancer-related pain, the use of opioids comes with a number of issues for both patients and prescribers.
3. Pharmacists Challenged With Amoxicillin, Adderall Shortages
Shortages are leaving patients in the lurch.
2. Breaking Down the Benefits and Risk of Co-Administration of COVID-19 and Flu Vaccines
Help protect patients by giving them the facts about getting both shots at once to save them a trip and increase rates of vaccination.
1. Flu Shots and Ischemic Stroke Risk in Older Adults
Recently published research reveals an important benefit for middle-aged and older adults: a reduction in ischemic stroke risk.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.